HLA typing in chronic type B, D and C hepatitis

Journal of Hepatology

Volumn 24, Issue 6, 1996, Pages 658-665

  Zavaglia, Claudio ^a   Bortolon, Cristina ^a   Ferrioli, Gabriella ^a   Rho, Anna ^a   Mondazzi, Luca ^a   Bottelli, Riccardo ^a   Ghessi, Alberto ^a   Gelosa, Franco ^a   Iamoni, Gianmaria ^a   Ideo, Gaetano ^a,b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Chronic hepatitis; HBV; HCV; HDV; HLA

Indexed keywords

HLA ANTIGEN;

ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; HEPATITIS B; HEPATITIS C; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030157661     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80260-1     Document Type: Article

References (50)

1. Male D, Champion B, Cooke A, Owen M. 2nd Edn Advanced Immunology. 12.1-12.22:1991;Gower Medical Publishing, London.
2. Stastny P, Ball EJ, Dry PJ, Nunez J. The human immune responsive region (HLA-D) and disease susceptibility. Immunol Rev. 70:1983;113-153.
3. Manns MP, Krüger M. Immunogenetics of chronic liver diseases. Gastroenterology. 106:1994;1676-1697.
4. Jeannet M, Farquet JJ. HL-A antigens in asymptomatic chronic HBsAg carriers. Lancet. ii:1974;1383-1384. (letter).
5. s antigenemia in hemodialysis patients. Lancet. 2:1975;707. (letter).
6. Boettcher B, Hay J, Watterson CA, Bashir H, MacQueen JM, Hardy G. Association between an HL-A antigen and Australia Antigen in Australian aborigenes. J Immunogenet. 2:1975;151-161.
7. Hillis WD, Hillis A, Bias WB, Walker WG. Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med. 296:1977;1310-1314.
8. Patterson MJ, Hourani MR, Mayor GH. HLA antigens and hepatitis B virus. N Engl J Med. 297:1977;1124. (letter).
9. Penner E, Grabner G, Dittrich H, Mayr WR. HLA antigens in HBs antigen positive chronic active hepatitis. Tissue Antigens. 10:1977;63-64.
10. Jagielski P, Sotnik D. HLA antigens in asymptomatic carriers of HBs antigen and in carriers of anti-HBs antibodies. Arch Immunol Ther Exp. 26:1978;207-212.
11. Sengar DPS, Rashid A, Jindal SL, Christie CJ. HLA antigens in HBsAg infection. Vox Sang. 36:1979;353-355.
12. Giani G, Chiaramonte M, Venturi Pasini C, Fagiolo U, Naccarato R. Hepatitis B surface antigenemia and HLA antigens. N Engl J Med. 300:1979;1056. (letter).
13. Májsky A, Horejsí J, Cerhová M, Korinková P, Mimra J, Novák J. Independent HBs antigen occurrence on HLA system. Tissue Antigens. 13:1979;170-171.
14. Shamszad M, Nikbin B, Farzadegan H, Ala F. Histocompatibility antigen (HLA) in HBs carriers and cirrhotics in Iran. Gastroenterology. 76:1979;1244. (abstr).
15. Coughlin GP, Van Deth AG, Disney APS, Hay J, Wangel AG. Liver disease and the e antigen in HBsAg carriers with chronic renal failure. GUT. 21:1980;118-122.
16. Sampliner RE, Bias WB, Carney E, Hillis A, Hillis WD. HLA antigens and HBV infection: evaluation in the chronic carrier state and in a large family. Tissue Antigens. 18:1981;247-251.
17. Carbonara A, Mayr W, Rizzetto M, Contu L, Curtoni ES, DeMarchi M, Farci P, Lavarini C, Olivetti E. Endemic HBV infection, tissue autoantibodies and HLA. Tissue Antigens. 22:1983;289-294.
18. Forzani B, Actis GC, Verme G, Amoroso A, Borelli I, Curtoni ES, Rumi MG, Picciotto A, Marinucci G, Freni MA, Rizzetto M. HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infection. Hepatology. 4:1984;1107-1110.
19. Black FL, Pandey JP, Capper RA. Hepatitis B epidemiology and its relation to immunogenetic traits in South American Indians. Am J Epidemiol. 123:1986;336-343.
20. Mota AH, Faiboim H, Terg R, Fainboim L. Associations of chronic active hepatitis and HLA B35 in patients with hepatitis B virus. Tissue Antigens. 30:1987;238-240.
21. Van Hattum J, Schreuder GMTh, Schalm SW. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology. 7:1987;11-14.
22. Sugiura S, Mizokami M, Orito E, Ina S, Kameshima N, Tanaka Y, Ogino M, Yamamoto M, Akaza T. DR locus-inclusive HLA in patients with persistent hepatitis B surface antigen. Zuckerman Aj. Viral Hepatitis and Liver Disease. 1988;684-687 Alan R. Liss, Inc, New York.
23. Yang PM, Sung JL, Chen DS. HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepatogastroenterology. 36:1989;363-366.
24. Thursz M, Hill A, Allsopp C, Kwiatkowski D, Greenwood B, Thomas HC. The MHC class II haplotype DRB1*1302-DRB3*0301-DQA1*0102-DQB1*0501 protects against persistent HBV infection. J Hepatol. 21:1994;S3. (Suppl. 1).
25. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet. 344:1994;1194-1195.
26. Diepolder HM, Jung M-C, Albert E, Hoffmann RM, Zachoval R, Pape GR. HLA and hepatitis B infection. Lancet. 344:1994;1772-1773.
27. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
28. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby lR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
29. Tibbs CJ, Manabe K, Donaldson P, Underhill JA, Eddleston ALWF, Williams R. Does host HLA class II status modulate susceptibility to HCV infection. Hepatology. 18:1993;259A. (abstr).
30. Kuzushita N, Hayashi N, Katayama K, Hiramatsu N, Yasumaru M, Shimizu Y, Kasahara A, Fusamoto H, Kamada T. HLA DR13 is a marker for low activity of hepatitis C virus carriers in Japan. Hepatology. 20:1994;237A. (abstr).
31. De Groote J, Gedigk P, Popper H, Scheuer PJ, Thaler N, Desmet VJ, Korb G, Poulsen H, Schmid M, Uehlinger E, Wepler W. A classification of chronic hepatitis. Lancet. ii:1968;626-628.
32. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. J Clin Pathol. 31:1978;395-414.
33. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
34. Smedile A, Lavarini C, Crivelli O, Raimondo G, Fassone M, Rizzetto M. Radioimmunoassay detection of IgM antibodies to the HDV-associated delta antigen: clinical significance in delta infection. J Med Virol. 9:1982;131-138.
35. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature. 204:1964;998-1000.
36. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM Th, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system 1991. Tissue Antigens. 39:1992;161-173.
37. Hawkins BR. Table of critical Chi-square values for investigations involving multiple comparisons. Tissue Antigens. 17:1981;243-244.
38. Tiwari JL, Terasaki PI. The data and the statistical methods. Tiwari JL, Terasaki PI. 1st Edn HLA and Disease Associations. 1985;18-27 Springer-Verlag, New York.
39. Bengtsson BO, Thomson G. Measuring the strength of associations between HLA antigens and diseases. Tissue Antigens. 18:1981;356-363.
40. Illeni MT, Turo G, Veratti MA, Barbanti M, Bombelli G, Bontempelli M, Carpanelli R, Cenzuales S, Ciavarella G, Conte R, De Filippo C, Fanetti G, Ferrioli M, Gambelunghe C, Gavioli A, Gentilini I, Guerra M, Innocenti P, Iorio M, Martinetti M, Mele L, Menardi G, Mulas G, Pagano M, Papolo F, Zacchi T. Polimorfismo HLA e popolazione ita-liana. La T.d. S. 39:1994;1-16.
41. Long EO, Jacobson S. Pathways of viral antigen processing and presentation to CTL. Immunol Today. 10:1989;45-48.
42. Gonzalez-Peralta RP, Davis GL, Lau JYN. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol. 21:1994;255-259.
43. Poralla T, Hütteroth TH, Meyer zum Büschenfelde K-H. Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis. Gut. 25:1984;114-120.
44. Mondelli M, Alberti A, Tremolada F, Williams R, Eddleston ALWF, Realdi G. In vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis. Clin Exp Immunol. 63:1986;147-155.
45. Opelz G, Mytilineos J, Scherer S, Dunckley H, Trejaut J, Chapman J, Middleton D, Savage D, Fischer O, Bignon J-D, Bensa J-C, Albert E, Noreen H. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet. 338:1991;461-463.
46. Bonino F, Brunetto MR, Negro F, Smedile A, Ponzetto A. Hepatitis Delta virus, a model of liver cell pathology. J Hepatol. 13:1991;260-266.
47. Milich DR, Chisari F. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 129:1982;320-325.
48. Milich DR, Leroux-Roels G, Chisari FV. Genetic regulation of the immune response to hepatitis B surface antigen (HB-sAg). II. Qualitative characteristics of the humoral immune response to the a, d and y determines of HBsAg. J Immunol. 130:1983;1395-1400.
49. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ. Genetic pre-disposition of nonresponse to hepatitis B vaccine. N Engl J Med. 321:1989;708-712.
50. Pol S, Legendre C, Mattlinger B, Berthelot P, Kreis H. Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients. J Hepatol. 11:1990;385-387.